Abstract 3901: Therapeutic targeting of LGR5-positive cancer stem cells

作者
María Carmen Mulero,Catherine E. Rice,Sukshala A. Jahdav,Willie Pi,Alexander Lin,Mindy Nguyen,Owen Tai,Stephen B. Howell
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 3901-3901
标识
DOI:10.1158/1538-7445.am2024-3901
摘要

Abstract Introduction: Destruction of cancer stem cells (CSC) is a major therapeutic goal. LGR5 marks active stem cells in many types of solid cancers. It has been very difficult to isolate good antibodies to native LGR5 and attempts to develop ADCs targeting LGR5 have not advanced. We took the alternative approach of using a natural LGR5 ligand to target monomethylauristatin (MMAE) to LGR5-expressing CSC. An Fc domain was fused to the LGR binding domains of RSPO1 and the sortase reaction was used to conjugate a Gly3-val/cit-PAB-MMAE linker at the C-terminal end to create FcF2-MMAE. We previously reported its efficacy in ovarian models here document its activity in other aggressive cancer models. Methods: FcF2-MMAE was produced by transient transfection in HEK293E cells and purified by a sequential Ni-NTA and ion exchange chromatography. OVCAR8 ovarian cancer cells were molecularly engineered to stably express an empty vector (OVCAR8/EV) or LGR5 (OVCAR8/LGR5.6) at a 10-fold higher level. The sortase A enzyme was produced in E. coli. Flow cytometry was used to quantify cell surface LGR5 in live cells using an anti-LGR5 antibody. Results: DEPMAP tools were used to identify cell types with high levels of WNT signaling that drives expression of LGR5. FCM confirmed LGR5 expression in colon LoVo, gastric AGS and neuroblastoma SKNAS cells. All three lines were very sensitive to FcF2-MMAE; GI50 values in 2D cultures were: LoVo 4.5, AGS 0.7 and SKNAS 8.6 nM. IC50 values for stem cell-derived spheroids grown from these lines were: 11.0, 3.0 and 1.70 nM, respectively. The MTD of FcF2-MMAE was found to be >1.5 nmol/g in mice. The plasma half-life was 29.7 h. A q7dx4 IP dose schedule was found to be more effective than a q4dx4 IP schedule. FcF2-MMAE inhibited in vivo SC growth in all 3 models at a dose of 1 nmol/g q7dx4, producing cures in a fraction of AGS tumors and delaying SKNAS growth >2-fold in the absence adverse events. In addition to MMAE, we showed that FcF2-His could be conjugated to the either deruxtecan or PNU159682; FcF2-His loaded with either one of these cytotoxins had low nM or sub nM cytotoxicity and retained the same high selectivity of FcF2-MMAE when tested in isogenic OVCAR8/EV and OVCAR8/LGR5 cells. Conclusions: FcF2-MMAE has activity in xenograft models of very aggressive tumors driven by high levels of WNT signaling (LoVo, AGS, and SKNAS) and LGR5 expression. Efficacy was obtained at doses well below its MTD indicating a wide therapeutic window. The FcF2 core accommodates multiple types of warheads without loss of targeting selectivity. The ability to switch out one cytotoxin for another provides versatility in targeting different diseases. FcF2-MMAE has advantages over ASCs. Its small size relative to antibodies favors better tumor penetration. The binding domains of RSPO1 also target stem cells expressing LGR4 and LGR6 as well as LGR5, something that cannot be achieved with an ADC. These features support the further development of FcF2-MMAE as a stem cell-targeted therapeutic. Citation Format: Maria Carmen Mulero, Catherine Rice, Sukshala A. Jahdav, Willie Pi, Alexander Lin, Mindy Nguyen, Owen Tai, Stephen B. Howell. Therapeutic targeting of LGR5-positive cancer stem cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3901.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张123完成签到 ,获得积分20
1秒前
1秒前
啵啵完成签到,获得积分10
2秒前
成就的鞋垫完成签到,获得积分10
2秒前
小舞的大树完成签到,获得积分10
2秒前
山茶完成签到,获得积分10
2秒前
坚定尔蓝完成签到,获得积分10
2秒前
七七完成签到,获得积分10
3秒前
3秒前
无极微光的应助被不想休息采纳,获得20
3秒前
文轩完成签到,获得积分10
3秒前
快乐的忆安完成签到,获得积分10
3秒前
小面包完成签到,获得积分10
3秒前
卷王完成签到,获得积分10
4秒前
5秒前
甜美的盼晴完成签到 ,获得积分10
5秒前
诊断性评估完成签到,获得积分10
5秒前
情怀的应助被风筝采纳,获得10
5秒前
kevin完成签到,获得积分10
5秒前
不勤劳的小蜜蜂完成签到,获得积分20
5秒前
nonory完成签到,获得积分10
5秒前
糟糕的学姐完成签到 ,获得积分10
6秒前
等待的鸡翅完成签到,获得积分10
7秒前
betterme完成签到,获得积分10
7秒前
Leo完成签到,获得积分0
8秒前
8秒前
过时的不评完成签到,获得积分10
8秒前
11完成签到 ,获得积分10
8秒前
未来学术司马懿完成签到,获得积分0
8秒前
兴奋小丸子完成签到,获得积分10
8秒前
畅想未来2026完成签到,获得积分10
8秒前
didida_he完成签到,获得积分10
9秒前
wsy完成签到 ,获得积分10
9秒前
kathleen完成签到,获得积分10
9秒前
廿二完成签到 ,获得积分10
9秒前
能干的尔竹完成签到,获得积分10
9秒前
lxy完成签到,获得积分10
9秒前
李李完成签到 ,获得积分10
9秒前
Star1983完成签到,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173463
求助须知:如何正确求助?哪些是违规求助? 9565690
关于积分的说明 21781315
捐赠科研通 7767647
什么是DOI,文献DOI怎么找? 3431597
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476808